HealthEquity Inc

Yesterday 4:12pm ET HealthEquity Expands Portfolio with Conduent Acquisition by TipRanks Apr 09 5:18am ET TipRanks’ ‘Perfect 10’ List: Analysts Throw Weight Behind These 2 Top-Scoring Stocks by TipRanks Apr 04 4:24am ET HealthEquity initiated with an Outperform at JMP Securities by TipRanks Apr 04 12:35am ET HealthEquity’s Market Leadership and Growth Trajectory Bolster Buy Rating by TipRanks Apr 02 5:38am ET JPMorgan ups HealthEquity target, adds to Analyst Focus List by TipRanks Apr 02 5:08am ET HealthEquity Poised for Strong Growth: Buy Rating with a $108 Price Target by TipRanks Mar 28 8:01am ET HealthEquity price target raised to $95 from $79 at Jefferies by TipRanks Mar 28 7:55am ET Jefferies Keeps Their Buy Rating on Healthequity (HQY) by TipRanks Mar 28 4:55am ET Buy Rating on Healthequity (HQY) Affirmed Amid HSA Market Growth and Competitive Outperformance by TipRanks Mar 26 8:02pm ET Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE) by TipRanks Mar 24 2:01am ET Navigating Uncertainty: Healthequity Inc. Grapples with HSA Asset Volatility and Revenue Risks by TipRanks Mar 22 9:15am ET HealthEquity Outperforms with Strong Quarterly Results and Positive Fiscal 2025 Outlook: Buy Rating Reaffirmed by TipRanks Mar 22 6:23am ET HealthEquity price target raised to $95 from $85 at KeyBanc by TipRanks Mar 22 3:40am ET Analysts’ Top Healthcare Picks: Healthequity (HQY), Exscientia Plc (EXAI) by TipRanks Mar 21 2:36am ET HealthEquity: A Strong Buy with Projected Earnings Growth and Market Leadership by TipRanks Mar 20 1:47pm ET HealthEquity price target raised to $110 from $100 at BTIG by TipRanks Mar 20 7:47am ET HealthEquity price target raised to $92 from $90 at RBC Capital by TipRanks Mar 20 7:15am ET Healthequity (HQY) Receives a Buy from RBC Capital by TipRanks Mar 20 6:22am ET HealthEquity price target raised to $97 from $93 at BofA by TipRanks Mar 20 6:01am ET Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA) by TipRanks Mar 20 5:10am ET Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY) by TipRanks Mar 20 3:15am ET Barclays Keeps Their Buy Rating on Healthequity (HQY) by TipRanks Mar 19 4:11pm ET HealthEquity sees FY25 EPS $2.79-$2.96, consensus $2.83 by TipRanks Mar 19 4:06pm ET HealthEquity reports Q4 EPS 63c, consensus 56c by TipRanks Mar 19 1:45am ET HealthEquity (HQY) Poised for Strong Growth and Resilience, Earns ‘Buy’ Rating by TipRanks Mar 14 6:16am ET Healthequity’s Financial Growth and Strategic Asset Management Shift Justify a Buy Rating by TipRanks Mar 13 4:23pm ET HealthEquity Expands HSA Market Share with Strategic Acquisition by TipRanks Feb 26 9:06am ET HealthEquity price target raised to $100 from $85 at Barrington by TipRanks Feb 23 10:02am ET HealthEquity price target raised to $90 from $77 at RBC Capital by TipRanks Feb 23 7:40am ET Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Insulet (PODD) and Healthequity (HQY) by TipRanks Feb 23 7:38am ET HealthEquity raises FY24 EPS view to $2.20-$2.24 from $2.08-$2.16 by TipRanks